“Pricing is the moment of truth”, but developing a pricing strategy for optimal market access is difficult. This is because the mix of payers who determine market access hurdles, changes with the country and the setting of care. Understanding value pricing in pharma’s multi-stakeholder and international environment is therefore critical for pricing executives, and for all functions interacting with key stakeholders in the market access process. This course will teach you the techniques and approaches that have been proven to work best for value pricing in pharma.
